Advertisement
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) Stock Overview

Explore Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A’s financial performance, market position, analyst ratings, and future outlook.

BRKRPNASDAQ
HealthcareMedical - Devices
$410.89
$8.60(2.05%)
U.S. Market opens in 16h 14m
Advertisement

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP)

Meyka AI Score

Z

Key Financials

Market Cap8.3B
P/E Ratio-749.06
EPS (TTM)N/A
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$273.39
3 Months$375.41
1 Year Target$429.49

BRKRP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $429.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -749.06 and a market capitalization of 8.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.21%
5-Day Change
-4.10%
1-Month Change
19.64%
3-Month Change
40.47%
6-Month Change
13.12%
Year-to-Date (YTD) Change
12.08%
1-Year Change
63.76%
3-Year Change
63.76%
5-Year Change
63.76%
All-Time (Max) Change
63.76%

Contact Information

978 663 3660
40 Manning Road, Billerica, MA, 01821

Company Facts

11,396 Employees
IPO DateSep 8, 2025
CountryUS
Actively Trading

Frequently Asked Questions